SNCA Produits
(Synuclein, alpha (SNCA))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories SNCA en vedette
SNCA Anticorps
High quality antibodies with extensive validation data.
SNCA Kits ELISA
Reliable ELISA kits for a wide range of species.
SNCA Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
SNCA recommandé Anticorps
- (7)
- (1)
- (4)
- (5)
SNCA recommandé Kits ELISA
- (2)
- (1)
- (5)
- (1)
- (3)
- (1)
SNCA recommandé Protéines
- (6)
- (9)
- (10)
Dernières publications sur nos produits SNCA
: "Neurorestorative effects of sub-chronic administration of ambroxol in rodent model of Parkinson's disease." dans: Naunyn-Schmiedeberg's archives of pharmacology, Vol. 393, Issue 3, pp. 429-444, (2021) (PubMed).: "Potential therapeutic effects of antagonizing adenosine A2A receptor, curcumin and niacin in rotenone-induced Parkinson's disease mice model." dans: Molecular and cellular biochemistry, Vol. 465, Issue 1-2, pp. 89-102, (2020) (PubMed).
: "Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease." dans: International journal of pharmaceutics, Vol. 579, pp. 119148, (2020) (PubMed).
: "Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys." dans: EBioMedicine, Vol. 59, pp. 102944, (2020) (PubMed).
: "Exosomes from patients with Parkinson's disease are pathological in mice." dans: Journal of molecular medicine (Berlin, Germany), Vol. 97, Issue 9, pp. 1329-1344, (2020) (PubMed).
: "Ambroxol modulates 6-Hydroxydopamine-induced temporal reduction in Glucocerebrosidase (GCase) enzymatic activity and Parkinson's disease symptoms." dans: Biochemical pharmacology, Vol. 155, pp. 479-493, (2019) (PubMed).
: "Neurodegenerative Disease-Related Proteins within the Epidermal Layer of the Human Skin." dans: Journal of Alzheimer's disease : JAD, Vol. 69, Issue 2, pp. 463-478, (2019) (PubMed).
: "Rosmarinic acid attenuates inflammatory responses through inhibiting HMGB1/TLR4/NF-κB signaling pathway in a mouse model of Parkinson's disease." dans: Life sciences, Vol. 223, pp. 158-165, (2019) (PubMed).
: "An Enriched Environment Ameliorates Oxidative Stress and Olfactory Dysfunction in Parkinson's Disease with α-Synucleinopathy." dans: Cell transplantation, Vol. 27, Issue 5, pp. 831-839, (2019) (PubMed).
: "Apelin-36 mitigates MPTP/MPP+-induced neurotoxicity: Involvement of α-synuclein and endoplasmic reticulum stress." dans: Brain research, Vol. 1721, pp. 146334, (2019) (PubMed).
Synonymes et noms alternatifs relatifs à SNCA
synuclein alpha L homeolog (snca.L), alpha-synuclein (LOC619283), synuclein alpha (SNCA), synuclein, alpha (Snca), synuclein alpha (Snca), alphaSYN, LOC619283, MGC64356, NACP, PARK1, PARK4, PD1, sncaProtein level used designations for SNCA
- synuclein, alpha
- alpha-synuclein
- alpha SYN
- non-A beta component of AD amyloid
- non-A4 component of amyloid
- non A-beta component of AD amyloid
- synuclein alpha-140
- alpha synuclein